Prediction of therapeutic uses of psychotherapeutic drugs from experiences with normal volunteers.
D000928:Antidepressive Agents / Q000627:therapeutic use*; D001702:Biopharmaceutics; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D003913:Dextroamphetamine / Q000627:therapeutic use; D005230:Fatty Acids, Nonesterified / Q000097:blood; D006213:Hallucinogens / Q000627:therapeutic use; D006805:Human Experimentation; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D008620:Meprobamate / Q000097:blood / Q000627:therapeutic use; D008954:Models, Biological; D010555:Personality Inventory; D011379:Prognosis; D012110:Reserpine / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D000928:Antidepressive Agents; D000697:Central Nervous System Stimulants; D005230:Fatty Acids, Nonesterified; D006213:Hallucinogens; D006993:Hypnotics and Sedatives; D014149:Tranquilizing Agents; D012110:Reserpine; D008620:Meprobamate; D003913:Dextroamphetamine